TABLE 1.
Characteristics of study animals
| Treatment and animal | Gender | Treatment initiation |
Wk 1–2 sampling |
Wk 5–6 sampling |
|||
|---|---|---|---|---|---|---|---|
| Datea | Wt (kg) | Date (no. of days posttreatment) | Wt (kg) | Date (no. of days posttreatment) | Wt (kg) | ||
| Control | |||||||
| Rh37034 | Male | 12.65 | 10-05-2016 | 11.97 | 11-02-2016 | 11.63 | |
| RhDFAi | Male | 9.38 | 10-05-2016 | 9.12 | 11-02-2016 | 8.45 | |
| RhDGGB | Male | 3.74 | 11-06-2017 | 3.76 | 12-04-2017 | 3.83 | |
| RhDGMh | Male | 3.39 | 11-06-2017 | 3.22 | 12-04-2017 | 3.42 | |
| RhDFK9 | Male | 7.32 | 1-30-2018 | 7.02 | 2-27-2018 | 7.15 | |
| RhDMEj | Female | 8.99 | 1-30-2018 | 8.65 | 2-27-2018 | 8.25 | |
| IN inhibitor | |||||||
| Rh37033 | Male | 9-27-2016 | 12.10 | 10-04-2016 (7) | 11.53 | ||
| RhDCKj | Male | 2-03-2015 | 9.61 | 2-10-2015 (7) | 9.63 | ||
| RhDCVf | Male | 2-03-2015 | 9.73 | 2-10-2015 (7) | 9.57 | ||
| RhDE1a | Male | 2-03-2015 | 11.85 | 2-10-2015 (7) | 11.67 | ||
| RhDE1aa | Male | 9-27-2016 | 6.21 | 10-04-2016 (7) | 6.05 | ||
| RhF64 | Female | 9-27-2016 | 7.73 | 10-04-2016 (7) | 7.71 | ||
| PR inhibitor | |||||||
| RhDCBC | Male | 3-09-2015 | 8.85 | 3-16-2015 (7) | 8.56 | ||
| RhDE20 | Male | 3-09-2015 | 9.66 | 3-16-2015 (7) | 9.31 | ||
| RhDE2c | Male | 3-09-2015 | 8.70 | 3-16-2015 (7) | 8.48 | ||
| RhDE2w | Male | 3-09-2015 | 13.20 | 3-16-2015 (7) | 13.08 | ||
| Rh37073 | Female | 9-27-2016 | 11.48 | 10-05-2016 (8) | 11.33 | 11-02-2016 (36) | 11.56 |
| Rh37360 | Female | 9-27-2016 | 10.83 | 10-05-2016 (8) | 10.75 | 11-02-2016 (36) | 11.63 |
| RhZC08 | Female | 9-27-2016 | 7.02 | 10-05-2016 (8) | 6.95 | 11-02-2016 (36) | 6.62 |
| RhDF8d | Male | 10-23-2017 | 4.58 | 11-07-2017 (15) | 4.5 | 12-05-2017 (43) | 4.63 |
| RhDFPn | Male | 10-23-2017 | 6.17 | 11-07-2017 (15) | 6.06 | 12-05-2017 (43) | 6.19 |
| RhDGHi | Male | 10-23-2017 | 3.32 | 11-07-2017 (15) | 3.2 | 12-05-2017 (43) | 3.46 |
| RhDGMp | Male | 10-23-2017 | 3.43 | 11-07-2017 (15) | 3.45 | 12-05-2017 (43) | 3.67 |
| RhDFNj | Male | 1-17-2018 | 8.45 | 01-29-2018 (12) | 8.26 | 02-25-2018 (39) | 8.62 |
| RhDFZc | Male | 1-17-2018 | 7.13 | 01-29-2018 (12) | 7.37 | 02-25-2018 (39) | 7.73 |
| RT inhibitor (FTC) | |||||||
| RhCL7p | Male | 1-20-2015 | 13.43 | 1-27-2015 (7) | 13.18 | ||
| RhDCAV | Male | 1-20-2015 | 9.37 | 1-27-2015 (7) | 9.05 | ||
| RhDCJWA | Male | 1-20-2015 | 9.63 | 1-27-2015 (7) | 9.58 | ||
| RT inhibitor (PMPA) | |||||||
| RhCL4c | Male | 9-30-2014 | 11.31 | 10-07-2014 (7) | 11.2 | ||
| RhCL86 | Male | 9-30-2014 | 11.64 | 10-07-2014 (7) | 11.54 | ||
| RhF98 | Female | 9-30-2014 | 7.23 | 10-07-2014 (7) | 7.1 | ||
a
All dates are given in the form month-day-year.